Indication for stereotactic radiotherapy of the macula with IRay® for wet age-related macular degeneratio

• Conditions: H35.3; Degeneration of macula and posterior pole

• Registration Number: DRKS00009593
• Lead Sponsor: niversitäts-Augenklinik Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-11-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

wet age related macular degeneration, previously treated with intravitreal injections

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients who are eligible for IRay treatment

Secondary Outcome Measures

Name	Time	Method
characteristics of patient eligible for IRay: clinical history (number of treatments within last 6/12 months, number of different drugs, visual acuity before treatment and at time of analysis); description of clinical evaluation (SRT offered/planned/performed/delayed); analysis of patient response to IRay treatment (declined? reasons); description of patients not eligible: reasons (characteristics of AMD, ocular comorbidity, systemic comobidity), was IRay possible at a time before this evaluation? description of clinical course of patients who were eligible before (number of intravitreal injections)